Craft

Nonacus

Revenue

£53.9 M

FY, 2021

Nonacus Summary

Company Summary

Overview
Nonacus is a biotech company specializing in genetic testing. It delivers technologies to the genomic healthcare sector through the use of cell free circulating DNA as a non-invasive diagnostic tool that is applicable for pre-analytical, oncology, prenatal healthcare, virus detection, and constitutional genetics diagnostics.
Type
Private
Status
Active
Founded
2015
HQ
Birmingham, GB | view all locations
Website
https://nonacus.com
Cybersecurity rating
Sectors

Key People

  • Chris Sale

    Chris Sale, Chief Executive Officer

  • Lee Silcock
  • Samuel Clokie

    Samuel Clokie, Director of Bioinformatics & Data Science

  • Johan Vanderhoeven

    Johan Vanderhoeven, Commercial Director

Operating MetricsView all

Product Categories

5

Jul, 2023

Industries Served

3

Jul, 2023

Certifications

1

Jul, 2023

LocationsView all

1 location detected

  • Birmingham, England HQ

    United Kingdom

    Vincent Drive, Birmingham Research Park

Nonacus Financials

Summary Financials

Revenue (FY, 2021)
£53.9M
Gross profit (FY, 2021)
£41.3M
Net income (FY, 2021)
£27.4M
Cash (FY, 2021)
£30.6M
EBIT (FY, 2021)
£33.9M

Footer menu